Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis.
Ling, Z
Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. [electronic resource] - Diabetes Mar 2000 - 340-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0012-1797
10.2337/diabetes.49.3.340 doi
Alloxan--pharmacology
Animals
Apoptosis--physiology
Cytokines--physiology
Dose-Response Relationship, Drug
Interleukin-1--pharmacology
Islets of Langerhans--drug effects
Male
Necrosis
Nitric Oxide Donors--pharmacology
Osmolar Concentration
Phenotype
Proteins--metabolism
Rats
Rats, Wistar
Streptozocin--pharmacology
Triazoles--pharmacology
Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis. [electronic resource] - Diabetes Mar 2000 - 340-5 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0012-1797
10.2337/diabetes.49.3.340 doi
Alloxan--pharmacology
Animals
Apoptosis--physiology
Cytokines--physiology
Dose-Response Relationship, Drug
Interleukin-1--pharmacology
Islets of Langerhans--drug effects
Male
Necrosis
Nitric Oxide Donors--pharmacology
Osmolar Concentration
Phenotype
Proteins--metabolism
Rats
Rats, Wistar
Streptozocin--pharmacology
Triazoles--pharmacology